Tag: GLP-1 RAs
What periop nurses should preoperatively know about GLP-1, oral GLP-1 drugs
With the explosion of GLP-1–based therapies for type 2 diabetes and weight loss, perioperative nursing teams, especially in the preoperative and postanesthesia care areas, need to be fluent in recognizing these medications. Some patients may arrive on these agents—or even novel oral GLP-1s—and the physiologic effects, especially delayed gastric emptying,…
GLP-1 drugs show promise for preoperative weight loss
Editor's Note Glucagon-like peptide-1 (GLP-1) receptor agonists may offer orthopedic patients with obesity and type 2 diabetes a powerful tool for preoperative weight loss and potential disease modification, according to a July 10 review article in The Journal of Bone and Joint Surgery. However, the agents carry perioperative risks that…
Free Daily News
- Higher MAP targets in acute spinal cord injury show no neurologic benefit, more complications
- Sports medicine procedures cost far less in ASCs than HOPDs
- Bariatric surgery outpaces GLP-1s in weight loss, cost savings
- Study finds overweight older adults have lower postsurgical mortality than peers with normal BMI
- FDA posts four device safety communications, prompting inventory, workflow checks
- 7 strategies healthcare leaders can use to turn around toxic workplace culture
- Nutrition screening tool predicts poor outcomes after pancreatic cancer surgery
- CDC reports 460% surge in drug-resistant NDM-CRE infections
- 5 reasons why perioperative leaders deserve to attend the 2025 OR Manager Conference
- Global medical community rejects Trump’s Tylenol-autism claims: Statements compilation
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement